申请人:G. D. Searle & Co.
公开号:US04188485A1
公开(公告)日:1980-02-12
The invention encompasses 1-[10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)methyl]-4-substituted piperidines and related compounds of the formula ##STR1## and the non-toxic pharmaceutically acceptable acid addition salts thereof; wherein R in each occurrence represents hydrogen, halogen, alkyl radical of 1 to 7 carbon atoms, or trifluoromethyl, alike or different; R.sup.1 is hydrogen or alkyl radical of 1 to 7 carbon atoms; Z is hydroxy or NR.sup.2 R.sup.3 group wherein R.sup.2 and R.sup.3 are each hydrogen or alkyl radical of 1 to 7 carbon atoms or R.sup.2 and R.sup.3 together with the N-atom represent an azamonocyclic ring which contains from 4 to 6 carbon atoms; X is ethylene, vinylene, oxy or thio; and m and n are each alike or different integer from 1 to 4 inclusive; and 1-(2,2-diarylethyl)-4-piperidinols of the formula ##STR2## and the non-toxic pharmaceutically acceptable acid addition salts thereof; wherein Ar is phenyl optionally substituted with one or more halogen or alkyl radical of 1 to 7 carbon atoms, alike or different; Ar.sup.1 is phenyl optionally substituted with one or more halogen or alkyl radical of 1 to 7 carbon atoms alike or different; and R.sup.4 is selected from the group consisting of hydrogen alkyl radical of 1 to 7 carbon atoms, 4-hydroxy-1-(2,2-diphenylethyl)-3-piperidinyl, and 4-oxo-1-(2,2-diphenylethyl)-3-piperidinyl. These compounds possess utility as neuroleptic agents.
本发明涉及公式为##STR1##的1-[10,11-二氢-5H-二苯并[a,d]环庚烯-5-基)甲基]-4-取代哌啶和相关化合物的非毒性药学上可接受的酸加成盐;其中R在每次出现时表示氢、卤素、1至7个碳原子的烷基基团或三氟甲基,相同或不同;R.sup.1是氢或1至7个碳原子的烷基基团;Z是羟基或NR.sup.2 R.sup.3基团,其中R.sup.2和R.sup.3分别是氢或1至7个碳原子的烷基基团,或者R.sup.2和R.sup.3与N原子一起表示含有4至6个碳原子的氮杂单环环;X是乙烯基、乙烯基、氧或硫;m和n是各自相同或不同的1至4个整数;以及公式为##STR2##的1-(2,2-二芳基乙基)-4-哌啶醇及其非毒性药学上可接受的酸加成盐;其中Ar是苯基,可选地取代一个或多个卤素或1至7个碳原子的烷基基团,相同或不同;Ar.sup.1是苯基,可选地取代一个或多个卤素或1至7个碳原子的烷基基团,相同或不同;R.sup.4选自羟基、1-(2,2-二苯基乙基)-4-哌啶基和4-氧代-1-(2,2-二苯基乙基)-3-哌啶基的群。这些化合物具有神经精神药物的功效。